Provenge Immunotherapy

Dendreon: The Revenge of Provenge
by: David Miller


DENDREON Scores a TOUCHDOWN with PROVENGE

by: Rory Kearney


Dendreon's Prostate Vaccine Boosts Survival

Dendreon's controversial Provenge cancer vaccine may get another chance two years after the FDA rejected it. The drugmaker's stock soared on the news